These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 7316247)

  • 21. Intranasal verapamil in allergen-induced rhinitis.
    Secher C; Brofeldt S; Mygind N
    Allergy; 1983 Nov; 38(8):565-70. PubMed ID: 6660435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammation.
    Kurowski M; Kuna P; Górski P
    Allergy; 2004 Mar; 59(3):280-8. PubMed ID: 14982509
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluticasone furoate nasal spray reduces the nasal-ocular reflex: a mechanism for the efficacy of topical steroids in controlling allergic eye symptoms.
    Baroody FM; Shenaq D; DeTineo M; Wang J; Naclerio RM
    J Allergy Clin Immunol; 2009 Jun; 123(6):1342-8. PubMed ID: 19428097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dose-ranging comparative evaluation of cetirizine in patients with seasonal allergic rhinitis.
    DuBuske L
    Ann Allergy Asthma Immunol; 1995 Apr; 74(4):345-54. PubMed ID: 7719897
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antihistamines added to an antileukotriene in treating seasonal allergic rhinitis: histamine and leukotriene antagonism.
    Ciprandi G; Tosca MA; Milanese M; Schenone G; Ricca V
    Eur Ann Allergy Clin Immunol; 2004 Feb; 36(2):67-70, 72. PubMed ID: 15061398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Experimentally induced nasal hypersecretion does not reduce the efficacy of intranasal levocabastine.
    Borum S; Nielsen K; Bisgaard H; Mygind N
    Rhinology; 1998 Dec; 36(4):153-5. PubMed ID: 9923056
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effectiveness and tolerability of the glucocorticoid mometasone furoate given as nasal spray in seasonal allergic rhinitis].
    Magyar P; Herjavecz I; Hirschberg A; Kraszkó P; Mohácsi E; Nékám K; Fónay K; Berta G; Györi Z; Márk Z
    Orv Hetil; 2000 Jun; 141(25):1407-11. PubMed ID: 10934885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of nimesulide alone and in combination with cetirizine in acute allergic rhinitis.
    Kotwani A; Puri R; Gupta U
    J Assoc Physicians India; 2001 May; 49():518-22. PubMed ID: 11361264
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of kinins in seasonal allergic rhinitis: icatibant, a bradykinin B2 receptor antagonist, abolishes the hyperresponsiveness and nasal eosinophilia induced by antigen.
    Turner P; Dear J; Scadding G; Foreman JC
    J Allergy Clin Immunol; 2001 Jan; 107(1):105-13. PubMed ID: 11149999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipopolysaccharide administration to the allergic nose contributes to lower airway inflammation.
    Bachar O; Gustafsson J; Jansson L; Adner M; Cardell LO
    Clin Exp Allergy; 2007 Dec; 37(12):1773-80. PubMed ID: 17941911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of intranasal fluticasone and salmeterol on allergen-induced nasal responses.
    Parameswaran K; Fanat A; O'Byrne PM
    Allergy; 2006 Jun; 61(6):731-6. PubMed ID: 16677243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nasal nitric oxide: longitudinal reproducibility and the effects of a nasal allergen challenge in patients with allergic rhinitis.
    Boot JD; de Kam ML; Mascelli MA; Miller B; van Wijk RG; de Groot H; Cohen AF; Diamant Z
    Allergy; 2007 Apr; 62(4):378-84. PubMed ID: 17362248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy of Tinospora cordifolia in allergic rhinitis.
    Badar VA; Thawani VR; Wakode PT; Shrivastava MP; Gharpure KJ; Hingorani LL; Khiyani RM
    J Ethnopharmacol; 2005 Jan; 96(3):445-9. PubMed ID: 15619563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluticasone propionate aqueous nasal spray reduces inflammatory cells in unchallenged allergic nasal mucosa: effects of single allergen challenge.
    Holm A; Dijkstra M; Kleinjan A; Severijnen LA; Boks S; Mulder P; Fokkens W
    J Allergy Clin Immunol; 2001 Apr; 107(4):627-33. PubMed ID: 11295650
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Seasonal non-allergic rhinitis (SNAR)--a new disease entity? A clinical and immunological comparison between SNAR, seasonal allergic rhinitis and persistent non-allergic rhinitis.
    Wedbäck A; Enbom H; Eriksson NE; Movérare R; Malcus I
    Rhinology; 2005 Jun; 43(2):86-92. PubMed ID: 16008061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined vs. single-entity pharmacologic inhibition of induced asthma.
    Falliers CJ; Redding MA
    Ann Allergy; 1980 Jun; 44(6):335-40. PubMed ID: 7386944
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exploratory study of the decongestive effect of Rhinopront syrup in adults and in children with acute rhinitis.
    Lebacq E; Gline JP; Joue P; Stockis A; Calderon P; Van Schoor O; Deroubaix X; Schwegler F
    Clin Trials Metaanal; 1994 Oct; 29(2-3):113-24. PubMed ID: 10151073
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of pruritus in allergic dermatoses: an evaluation of the relative efficacy of cyproheptadine and hydroxyzine.
    Baraf CS
    Curr Ther Res Clin Exp; 1976 Jan; 19(1):32-38. PubMed ID: 812662
    [No Abstract]   [Full Text] [Related]  

  • 39. Nasal challenge with serotonin in asymptomatic hay fever patients.
    Tønnesen P; Schaffalitzky de Muckadell OB; Mygind N
    Allergy; 1987 Aug; 42(6):447-50. PubMed ID: 2444128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-response relationship of a topical nasal decongestant: phenylpropanolamine.
    Bende M; Andersson KE; Johansson CJ; Sjögren C; Svensson G
    Acta Otolaryngol; 1984; 98(5-6):543-7. PubMed ID: 6084394
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.